FDA Approved: TORSEMIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Torsemide from Rising Pharma Holdings, Inc. under an ANDA (ANDA078249).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Heart Failure
• Liver Cirrhosis
• Nephrotic Syndrome
• Renal Disease

Drugs mentioned

• Torsemide (torsemide)

Snippet

SUPPL AP for TORSEMIDE (TORSEMIDE)